Literature DB >> 24377313

Pre-mRNA splicing-modulatory pharmacophores: the total synthesis of herboxidiene, a pladienolide-herboxidiene hybrid analog and related derivatives.

Chandraiah Lagisetti1, Maria V Yermolina, Lalit Kumar Sharma, Gustavo Palacios, Brett J Prigaro, Thomas R Webb.   

Abstract

Herboxidiene is a natural product that has previously been shown to exhibit antitumor activity by targeting the spliceosome. This activity makes herboxidiene a valuable starting point for the development of anticancer drugs. Here, we report an improved enantioselective synthesis of herboxidiene and the first report of its biologically active totally synthetic analog: 6-norherboxidiene. The synthesis of the tetrahydropyran moiety utilizes the novel application of inverse electron-demand Diels-Alder chemistry and the Ferrier-type rearrangement as key steps. We report, for the first time, cytotoxicity IC50s for synthetic herboxidiene and analogs in human tumor cell lines. We have also demonstrated that synthetic herboxidiene and its analogs can potently modulate the alternate splicing of MDM-2 pre-mRNA.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24377313      PMCID: PMC3962696          DOI: 10.1021/cb400695j

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  40 in total

1.  Stereospecific synthesis of cryptophycin 1.

Authors:  Lian-Hai Li; Marcus A Tius
Journal:  Org Lett       Date:  2002-05-16       Impact factor: 6.005

2.  Enantioselective synthesis of pladienolide B and truncated analogues as new anticancer agents.

Authors:  Vemula Praveen Kumar; Srivari Chandrasekhar
Journal:  Org Lett       Date:  2013-07-03       Impact factor: 6.005

3.  Sudemycins, novel small molecule analogues of FR901464, induce alternative gene splicing.

Authors:  Liying Fan; Chandraiah Lagisetti; Carol C Edwards; Thomas R Webb; Philip M Potter
Journal:  ACS Chem Biol       Date:  2011-03-07       Impact factor: 5.100

4.  Design, synthesis and initial biological evaluation of a novel pladienolide analog scaffold.

Authors:  Mahesh Kumar Gundluru; Alan Pourpak; Xiaoli Cui; Stephan W Morris; Thomas R Webb
Journal:  Medchemcomm       Date:  2011-01-01       Impact factor: 3.597

5.  Reduced fidelity of branch point recognition and alternative splicing induced by the anti-tumor drug spliceostatin A.

Authors:  Anna Corrionero; Belén Miñana; Juan Valcárcel
Journal:  Genes Dev       Date:  2011-03-01       Impact factor: 11.361

Review 6.  The development and application of small molecule modulators of SF3b as therapeutic agents for cancer.

Authors:  Thomas R Webb; Amanda S Joyner; Philip M Potter
Journal:  Drug Discov Today       Date:  2012-08-03       Impact factor: 7.851

Review 7.  The spliceosome as a target of novel antitumour drugs.

Authors:  Sophie Bonnal; Luisa Vigevani; Juan Valcárcel
Journal:  Nat Rev Drug Discov       Date:  2012-11       Impact factor: 84.694

8.  Pladienolides, new substances from culture of Streptomyces platensis Mer-11107. III. In vitro and in vivo antitumor activities.

Authors:  Yoshiharu Mizui; Takashi Sakai; Masao Iwata; Toshimitsu Uenaka; Kiyoshi Okamoto; Hajime Shimizu; Takao Yamori; Kentaro Yoshimatsu; Makoto Asada
Journal:  J Antibiot (Tokyo)       Date:  2004-03       Impact factor: 2.649

9.  Splicing factor SF3b as a target of the antitumor natural product pladienolide.

Authors:  Yoshihiko Kotake; Koji Sagane; Takashi Owa; Yuko Mimori-Kiyosue; Hajime Shimizu; Mai Uesugi; Yasushi Ishihama; Masao Iwata; Yoshiharu Mizui
Journal:  Nat Chem Biol       Date:  2007-07-22       Impact factor: 15.040

10.  Genomics-guided discovery of thailanstatins A, B, and C As pre-mRNA splicing inhibitors and antiproliferative agents from Burkholderia thailandensis MSMB43.

Authors:  Xiangyang Liu; Sreya Biswas; Michael G Berg; Christopher M Antapli; Feng Xie; Qi Wang; Man-Cheng Tang; Gong-Li Tang; Lixin Zhang; Gideon Dreyfuss; Yi-Qiang Cheng
Journal:  J Nat Prod       Date:  2013-03-21       Impact factor: 4.050

View more
  28 in total

1.  A triple exon-skipping luciferase reporter assay identifies a new CLK inhibitor pharmacophore.

Authors:  Yihui Shi; Jaehyeon Park; Chandraiah Lagisetti; Wei Zhou; Lidia C Sambucetti; Thomas R Webb
Journal:  Bioorg Med Chem Lett       Date:  2016-12-24       Impact factor: 2.823

2.  High-throughput single-molecule screen for small-molecule perturbation of splicing and transcription kinetics.

Authors:  Christopher R Day; Huimin Chen; Antoine Coulon; Jordan L Meier; Daniel R Larson
Journal:  Methods       Date:  2015-11-30       Impact factor: 3.608

3.  NTR1 is required for transcription elongation checkpoints at alternative exons in Arabidopsis.

Authors:  Jakub Dolata; Yanwu Guo; Agnieszka Kołowerzo; Dariusz Smoliński; Grzegorz Brzyżek; Artur Jarmołowski; Szymon Świeżewski
Journal:  EMBO J       Date:  2015-01-07       Impact factor: 11.598

Review 4.  Therapeutic targeting of splicing in cancer.

Authors:  Stanley Chun-Wei Lee; Omar Abdel-Wahab
Journal:  Nat Med       Date:  2016-09-07       Impact factor: 53.440

Review 5.  A Challenging Pie to Splice: Drugging the Spliceosome.

Authors:  Brian León; Manoj K Kashyap; Warren C Chan; Kelsey A Krug; Januario E Castro; James J La Clair; Michael D Burkart
Journal:  Angew Chem Int Ed Engl       Date:  2017-08-15       Impact factor: 15.336

6.  Spliceostatin hemiketal biosynthesis in Burkholderia spp. is catalyzed by an iron/α-ketoglutarate-dependent dioxygenase.

Authors:  Alessandra S Eustáquio; Jeffrey E Janso; Anokha S Ratnayake; Christopher J O'Donnell; Frank E Koehn
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-05       Impact factor: 11.205

Review 7.  Modulating splicing with small molecular inhibitors of the spliceosome.

Authors:  Kerstin A Effenberger; Veronica K Urabe; Melissa S Jurica
Journal:  Wiley Interdiscip Rev RNA       Date:  2016-07-21       Impact factor: 9.957

Review 8.  Biology of the mRNA Splicing Machinery and Its Dysregulation in Cancer Providing Therapeutic Opportunities.

Authors:  Maxime Blijlevens; Jing Li; Victor W van Beusechem
Journal:  Int J Mol Sci       Date:  2021-05-12       Impact factor: 5.923

9.  Design, synthesis and in vitro splicing inhibition of desmethyl and carba-derivatives of herboxidiene.

Authors:  Arun K Ghosh; Kai Lv; Nianchun Ma; Emilio L Cárdenas; Kerstin A Effenberger; Melissa S Jurica
Journal:  Org Biomol Chem       Date:  2016-05-18       Impact factor: 3.876

Review 10.  Roles and mechanisms of alternative splicing in cancer - implications for care.

Authors:  Sophie C Bonnal; Irene López-Oreja; Juan Valcárcel
Journal:  Nat Rev Clin Oncol       Date:  2020-04-17       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.